JPH04131082A - Production of non-aqueous highly active enzyme - Google Patents

Production of non-aqueous highly active enzyme

Info

Publication number
JPH04131082A
JPH04131082A JP2251853A JP25185390A JPH04131082A JP H04131082 A JPH04131082 A JP H04131082A JP 2251853 A JP2251853 A JP 2251853A JP 25185390 A JP25185390 A JP 25185390A JP H04131082 A JPH04131082 A JP H04131082A
Authority
JP
Japan
Prior art keywords
enzyme
surfactant
lipid
highly active
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2251853A
Other languages
Japanese (ja)
Inventor
Shinichirou Tawaki
新一郎 田脇
Mamoru Takeichi
竹市 守
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Priority to JP2251853A priority Critical patent/JPH04131082A/en
Publication of JPH04131082A publication Critical patent/JPH04131082A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Abstract

PURPOSE:To reproduce the subject enzyme useful in the fields of pharmaceuticals, foods, etc., utilizing waste liquid of a production process by adding a surfactant and a lipid to a buffer solution containing enzyme, a surfactant and a lipid as solutes and cooling the mixture. CONSTITUTION:The objective enzyme can be produced by dissolving a surfactant (e.g. lauric acid) in a buffer solution (e.g. waste liquid discharged from a production process) containing >=0.7mg/ml of an enzyme, a surfactant and a lipid as salutes, dispersing a lipid (e.g. monogalactosyl diglyceride or phosphatidylcholine) in the solution and cooling preferably to 0-10 deg.C. The weight ratio of the enzyme to the total surfactant (surfactant/enzyme) is adjusted to 0.001-1,000 and the weight ratio of enzyme to total lipid (lipid/enzyme) to 0.2-100.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、医薬品工業、食品工業、農水産分野及び有機
中間原料製造分野等において、エステル類やペプチド類
等の生理活性物質、及び光学活性な有機中間原料等の製
造に使用する非水系高活性酵素の製造方法に関するもの
である。
Detailed Description of the Invention [Industrial Field of Application] The present invention is useful in the pharmaceutical industry, food industry, agriculture and fishery fields, organic intermediate raw material production fields, etc. The present invention relates to a method for producing a non-aqueous highly active enzyme used in the production of organic intermediate raw materials.

〔従来の技術〕[Conventional technology]

酵素の優れた特性を有機合成に有効に利用するためには
、基質及び生成物の溶解層の点から有機溶媒の使用が必
須である。
In order to effectively utilize the excellent properties of enzymes in organic synthesis, it is essential to use organic solvents from the standpoint of dissolving substrates and products.

従来、有m溶媒中における酵素反応としては、酵素を有
機溶媒に?A濁させ反応させる不均一系の反応(A、M
、K11banov et al、、 CHEMTEC
)1.16.354(1986) )と、酵素を有IR
’l@媒に完全に熔解させ反応させる均−系の反応があ
る。
Conventionally, enzyme reactions in organic solvents involve using enzymes in organic solvents. Heterogeneous reaction (A, M
, K11banov et al., CHEMTEC
) 1.16.354 (1986) ) and enzymes with IR
There is a homogeneous reaction in which the substance is completely dissolved in a medium and reacts.

不均一系の反応においては、酵素が有機溶媒に懸濁して
いるため、基質の酵素内部への拡散が低く、反応性が低
い。そのため均−形系の反応が望ましいが、そのために
は酵素を可溶化する必要がある。
In a heterogeneous reaction, since the enzyme is suspended in an organic solvent, diffusion of the substrate into the enzyme is low, resulting in low reactivity. Therefore, a homogeneous reaction is desirable, but for this purpose it is necessary to solubilize the enzyme.

酵素の可溶化方法としては、酵素をポリエチレングリコ
ールで修飾し、有機ン容媒に可溶化する方法(Y、In
ada et al、、Biochem、Biophy
s、Res、Commun、、」η、 845 (19
134))があるが、調製方法が煩雑である。また、酵
素と脂質の複合体を形成さセ、有I!溶媒に可溶化する
方法(特開昭64−80282)があるが、複合体中に
含まれる酵素量が低く、かつ複合体の収量も低い等の問
題点がある。
As a method for solubilizing the enzyme, the enzyme is modified with polyethylene glycol and solubilized in an organic medium (Y, In
ada et al, Biochem, Biophy
s,Res,Commun,,”η, 845 (19
134)), but the preparation method is complicated. In addition, complexes between enzymes and lipids are formed. Although there is a method of solubilizing the enzyme in a solvent (Japanese Patent Laid-Open No. 64-80282), there are problems such as the amount of enzyme contained in the complex is low and the yield of the complex is also low.

本発明者は先に酵素と界面活性剤と脂質の複合体である
有機溶媒に可溶な非水系高活性酵素を見出し特許出願を
した(特願平2−081040号)。該複合体よりなる
酵素は例えば酵素をpu 5.0〜9.0の緩衝液に溶
解させておき、これに緩衝液に溶解させた界面活性剤を
滴下混合し、脂質を分散させこれを低温下に放置するこ
とにより複合体を析出させることにより製造することが
できる。しかし、この方法による場合は使用する酵素の
うち複合体となる割合は必ずしも多くなく、かなりの部
分が廃液中に残存してしまうという欠点を有していた。
The present inventor previously discovered a non-aqueous highly active enzyme that is a complex of an enzyme, a surfactant, and a lipid and is soluble in organic solvents and filed a patent application (Japanese Patent Application No. 2-081040). For example, the enzyme made of the complex is prepared by dissolving the enzyme in a buffer solution with a pu of 5.0 to 9.0, adding a surfactant dissolved in the buffer solution dropwise, dispersing the lipids, and then heating the solution at a low temperature. It can be produced by allowing the composite to precipitate by standing under. However, this method has the disadvantage that the proportion of the enzyme used that forms a complex is not necessarily large, and a considerable portion remains in the waste liquid.

[発明が解決しようとする課題] 本発明が解決しようとする課題は、前記酵素、界面活性
剤および脂質の複合体である非水系高活性酵素の製造プ
ロセスから排出される廃液中の酵素等を有効に利用し、
これより非水系高活性酵素を製造する方法を提供するこ
とである。
[Problem to be Solved by the Invention] The problem to be solved by the present invention is to remove enzymes, etc. from the waste liquid discharged from the manufacturing process of the non-aqueous highly active enzyme, which is a complex of the enzyme, surfactant, and lipid. Make effective use of
The object of the present invention is to provide a method for producing a non-aqueous highly active enzyme.

[課題を解決するための手段〕 上記本発明の目的は、酵素、界面活性剤および脂質が溶
解してなる緩衝液に、更に界面活性剤を溶解し、脂質を
分散し、冷却することを特徴とする、酵素と界面活性剤
と脂質の複合体である非水系高活性酵素を製造する方法
により達成される。
[Means for Solving the Problems] The object of the present invention is to further dissolve a surfactant in a buffer solution containing an enzyme, a surfactant, and a lipid, disperse the lipid, and cool the solution. This is achieved by a method for producing a non-aqueous highly active enzyme, which is a complex of an enzyme, a surfactant, and a lipid.

本発明における酵素、界面活性剤および脂質が溶解して
なる緩衝液とは、pH5,0〜9.0の緩衝液に酵素、
界面活性剤および脂質を溶解または分散したものでもよ
いが、本発明の目的からすれば前記特願平2−0810
40号の非水系高活性酵素を製造した廃液を使用するの
が好適である。すなわち、酵素をpH5,0〜9.0の
緩衝液に熔解させておき、これに緩衝液に溶解させた界
面活性剤を滴下混合し、これを低温下に放置冷却するこ
とにより複合体を析出させ、この析出した複合体を除い
たあとの液を使用する。さらには本発明に従って製造し
た非水系高活性酵素の廃液でもよい。
In the present invention, the buffer solution in which enzymes, surfactants, and lipids are dissolved refers to the enzyme, surfactant, and lipid dissolved in a buffer solution with a pH of 5.0 to 9.0.
A solution or dispersion of a surfactant and a lipid may also be used, but for the purpose of the present invention,
It is preferable to use the waste liquid from which No. 40 non-aqueous highly active enzyme was produced. That is, the enzyme is dissolved in a buffer solution with a pH of 5.0 to 9.0, a surfactant dissolved in the buffer solution is added dropwise to the solution, and the complex is precipitated by leaving it to cool at a low temperature. and use the solution after removing this precipitated complex. Furthermore, a waste liquid of a non-aqueous highly active enzyme produced according to the present invention may also be used.

緩衝液中の酵素の濃度は0.7g/111以上である。The concentration of enzyme in the buffer is 0.7 g/111 or more.

0.7u/d未満では複合体が析出しない。At less than 0.7 u/d, the composite does not precipitate.

本発明に使用できる酵素としては、加水分解酵素、転移
酵素、酸化還元酵素、付加酵素及び異性化酵素等を挙げ
ることができる。
Examples of enzymes that can be used in the present invention include hydrolases, transferases, oxidoreductases, addition enzymes, and isomerases.

加水分解酵素としてはエステラーゼ、ペプチダーゼ、グ
リコシダーゼ、ホスファターゼ、アミダーゼ等があげら
れる。
Examples of hydrolytic enzymes include esterase, peptidase, glycosidase, phosphatase, and amidase.

エステルを加水分解するエステラーゼでは、リパーゼも
しくはリパーゼを含有する生体組織を用いることができ
る。それらは微生物により生産されたものでもよいし、
動物の臓器や植物の種子等から得られたものでもよい。
As an esterase that hydrolyzes esters, lipase or a living tissue containing lipase can be used. They may be produced by microorganisms,
It may also be obtained from animal organs, plant seeds, etc.

ペプチドを加水分解するペプチダーゼでは、動物由来の
ペプシン、キモトリプシン、カルボキシペプチダーゼ、
サーモライシン;植物由来のパパイン、ブロメリン、ア
ミノペプチダーゼ;バクテリア由来のゲラチナーゼ、ジ
ペプチダーゼ等が挙げられる。糖のゲルコント結合に作
用するグリコシダーゼでは、α−及びβ−グリコシダー
ゼ、α−及びβ−ガラクシダーゼ等のオリゴサッカラー
ゼ、α−及びβ−アミラーゼ、セルラーゼ等のポリサン
カラーゼ等が挙げられる。リン酸結合の加水分解に関与
するホスファターゼでは、ホスホモノエステラーゼ、ホ
スホジェステラーゼ、ピロホスファターゼ等が挙げられ
る。アミド基を加水分解するアミダーゼでは、アルギナ
ーゼ、ウレアーゼ、グルタミナーゼ等が挙げられる。
Peptidases that hydrolyze peptides include animal-derived pepsin, chymotrypsin, carboxypeptidase,
Examples include thermolysin; plant-derived papain, bromelin, and aminopeptidase; and bacterial-derived gelatinase and dipeptidase. Examples of glycosidases that act on Gelconte bonds of sugars include oligosaccharases such as α- and β-glycosidases, α- and β-galaxidases, polysancarases such as α- and β-amylases, and cellulases. Phosphatases involved in hydrolysis of phosphate bonds include phosphomonoesterase, phosphogesterase, pyrophosphatase, and the like. Amidases that hydrolyze amide groups include arginase, urease, glutaminase, and the like.

加水分解酵素以外の酵素としては、トランスペプチダー
ゼ、トランスグルコシダーゼ、トランスペプチダーゼ、
トランスアミダーゼ、トランスグルタミナーゼ等の転移
酵素;アルコールデヒドロゲナーゼ、オキシゲナーゼ等
の酸化還元酵素;アコニターゼ、エノラーゼ、アスパル
ターゼ等の付加酵素;イソメラーゼ等の異性化酵素等が
挙げられる。
Enzymes other than hydrolytic enzymes include transpeptidase, transglucosidase, transpeptidase,
Examples include transferases such as transamidase and transglutaminase; oxidoreductases such as alcohol dehydrogenase and oxygenase; addition enzymes such as aconitase, enolase and aspartase; and isomerases such as isomerase.

本発明に用いられる界面活性剤は、非イオン系のものと
して、トリトンX−100等のポリオキシエチレンp−
t−オクチルフェニルエーテル;ディスホームCA−1
15;ノニオンE−215、ノニオンP−210等のポ
リエチレングリコールモノアルキルエーテル;ノニオン
NS−210,ノニオンH8−210等のポリエチレン
グリコール−p−アルキルフェニルエーテル;ノニオン
し−4、ノニオンS−6等のポリエチレングリコール脂
肪酸;スパン80、スパン85等のソルビタン脂肪酸;
ツウィーン20、ノニオンS−221等のソルビタンエ
ステルエーテル脂肪酸等が挙げられる。ここで、ディス
ホームCA−115、ノニオンE−215、ノニオンP
−210、ノニオンNS−210、ノニオンH320、
ノニオンL−4、ノニオンS−6、スパン80、スパン
85、ツウィーン20、ノニオンLT−221は日本油
脂■製の商品名である。アニオン系のものとして、ラウ
リル酸、ミリスチン酸、パルミチン酸、ステアリン酸、
オレイン酸等の脂肪酸とその塩;オクチルマロン酸塩、
ドデシルマロン酸塩等のアルキルマロン酸塩;オクチル
硫酸塩、デンル硫酸塩、ドデシル硫酸塩等のアルカンス
ルホン酸塩;α−スルホラウリン酸、α−スルホパルミ
チン酸等のα−スルホ脂肪酸である。カチオン系のもの
として、N−ドデシルピリジニウム塩等のN−アルキル
ピリジニウム塩、ドデシルアンモニウムクロライド、七
チルトリメチルアンモニウムクロライド等のアルキルア
ンモニウム塩等が挙げられる。
The surfactant used in the present invention is a nonionic surfactant such as polyoxyethylene p-
t-Octyl phenyl ether; Disform CA-1
15; Polyethylene glycol monoalkyl ethers such as Nonion E-215 and Nonion P-210; Polyethylene glycol-p-alkylphenyl ethers such as Nonion NS-210 and Nonion H8-210; Nonion Shi-4, Nonion S-6, etc. Polyethylene glycol fatty acids; sorbitan fatty acids such as Span 80 and Span 85;
Examples include sorbitan ester ether fatty acids such as Tween 20 and Nonion S-221. Here, Disform CA-115, Nonion E-215, Nonion P
-210, Nonion NS-210, Nonion H320,
Nonion L-4, Nonion S-6, Span 80, Span 85, Tween 20, and Nonion LT-221 are trade names manufactured by NOF ■. Anionic acids include lauric acid, myristic acid, palmitic acid, stearic acid,
Fatty acids and their salts such as oleic acid; octyl malonate,
These include alkyl malonates such as dodecyl malonate; alkanesulfonates such as octyl sulfate, delen sulfate, and dodecyl sulfate; and α-sulfo fatty acids such as α-sulfolauric acid and α-sulfopalmitic acid. Examples of cationic salts include N-alkylpyridinium salts such as N-dodecylpyridinium salts, alkyl ammonium salts such as dodecyl ammonium chloride, and heptyltrimethylammonium chloride.

本発明に用いることのできる脂質は、例えば、天然に存
在するものとしては、中性脂質、アニオン性脂質、両性
脂質等がある。
Lipids that can be used in the present invention include, for example, naturally occurring lipids such as neutral lipids, anionic lipids, and amphoteric lipids.

中性脂質では、モノガラクトシルジグリセリド、ガラク
トシルグルコシルジグリセリド等のグリセロ糖脂質;モ
ノグリコジルセラミド、セラミドへキソシド、ガングリ
オシド等のスフィンゴ糖脂質;ステロール配糖体、カル
デノリド配糖体、サポニン等のステロイド配糖体;ジア
シルトレハロース、トリアジルグルコース、ソルビタン
ジステアリン酸エステル、ショ糖ジステアリン酸エステ
ル等の脂肪酸糖等を挙げることができる。アニオン性脂
質では、ホスファチジルイノシトール、ホスファチジル
グリセロール、ホスファチジン酸等のリン脂質、また、
両性脂質では、ホスファチジルコリン、ホスファチジル
エタノールアミン、ホスファチジルセリン等のリン脂質
等を挙げることができる。
Neutral lipids include glyceroglycolipids such as monogalactosyl diglyceride and galactosyl glucosyl diglyceride; glycosphingolipids such as monoglycodylceramide, ceramide hexoside, and ganglioside; steroid glycosides such as sterol glycosides, cardenolide glycosides, and saponins. Examples include fatty acid sugars such as diacyltrehalose, triadylglucose, sorbitan distearate, and sucrose distearate. Anionic lipids include phospholipids such as phosphatidylinositol, phosphatidylglycerol, and phosphatidic acid;
Examples of amphoteric lipids include phospholipids such as phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine.

合成脂質としては、炭素数6〜30の2本の炭化水素鎖
を疎水部分とし、糖等のポリヒドロキシ基、リン酸基、
スルホンt11基、アンモニウム塩等の官能基を親水部
分として有する合成2分子膜形成化合物を用いることが
できる。具体的には、ジアルキルホスフェート、ジアル
キル型ポリエチレングリコール、ジアルキルスルホコハ
ク酸、ジアルキル型糖脂質、ジアルキルアンモニウム塩
等を挙げることができる。
Synthetic lipids include two hydrocarbon chains with 6 to 30 carbon atoms as hydrophobic parts, polyhydroxy groups such as sugars, phosphate groups,
A synthetic bilayer membrane-forming compound having a functional group such as a sulfone t11 group or an ammonium salt as a hydrophilic moiety can be used. Specifically, dialkyl phosphates, dialkyl polyethylene glycols, dialkyl sulfosuccinic acids, dialkyl glycolipids, dialkyl ammonium salts and the like can be mentioned.

全界面活性剤の全酵素に対する割合は0.001〜10
00 (界面活性剤重量/酵素重量)であり、緩衝液に
予め溶解しているものと後から添加したものの区別はな
い。緩衝液に海面活性剤を熔解するには常法に従えばよ
い。
The ratio of total surfactant to total enzyme is 0.001-10
00 (surfactant weight/enzyme weight), and there is no distinction between those dissolved in the buffer beforehand and those added later. A conventional method may be used to dissolve the surfactant in the buffer solution.

脂tは少1のメタノール、エタノール、プロパツール、
アセトン、メチルエチルケトン、その他の親水性有機溶
媒もしくは緩衝液に熔解し、またはそのまま用いる。
For fat, use 1 small amount of methanol, ethanol, propatool,
Dissolve in acetone, methyl ethyl ketone, other hydrophilic organic solvents or buffers, or use as is.

全脂質の全酵素に対する割合は0.2〜100(脂質重
量/酵素重量)であり、緩衝液に予め溶解しているもの
と後から添加したものの区別はない。
The ratio of total lipids to total enzymes is 0.2 to 100 (lipid weight/enzyme weight), and there is no distinction between those dissolved in the buffer solution in advance and those added later.

脂質の分散方法は、攪拌羽根やマグネチックスタラー、
ホモミキサー等の撹拌装置を用いてもよいし、超音波を
かけて分散させてもよい。
Lipid dispersion methods include stirring blades, magnetic stirrers,
A stirring device such as a homomixer may be used, or ultrasonic waves may be applied for dispersion.

脂質を十分に分散後、緩衝液を0〜30℃、好ましくは
、0〜10°Cに放置することにより、酵素と界面活性
剤と脂質の複合体を析出し、沈澱させる。この時、上澄
液には酵素、界面活性剤及び脂質が溶解している。この
上澄液は再度本発明の緩衝液として使用可能である。
After the lipids are sufficiently dispersed, the buffer solution is allowed to stand at 0 to 30°C, preferably 0 to 10°C, to precipitate and precipitate the enzyme-surfactant-lipid complex. At this time, enzymes, surfactants, and lipids are dissolved in the supernatant. This supernatant can be used again as a buffer in the present invention.

この沈澱物をを遠心分離または濾過等により分離した後
、緩衝液、次いで蒸留水で洗浄し、そのまま凍結乾燥や
流動層乾燥し、または、少量の蒸留水に分散させた後に
、スプレー乾燥することにより、粉末状の非水系高活性
酵素を得る。
After separating this precipitate by centrifugation or filtration, it is washed with a buffer solution and then with distilled water, and then it is freeze-dried or fluidized bed-dried as it is, or it is dispersed in a small amount of distilled water and then spray-dried. A powdered non-aqueous highly active enzyme is obtained.

〔実施例〕〔Example〕

以下、本発明を実施例により、詳細に説明する。 Hereinafter, the present invention will be explained in detail with reference to Examples.

実、雄側1 キャンディダ・シリンドラセ(Candid Cyli
n−dracea )由来のリパーゼ501gを酢酸緩
衝液(0,01M、 p H6,0) 25mに溶解後
、遠心沈腎させて、不溶物を除いた(a液)。非イオン
界面活性剤(ノニオンLT−221:商品名、日本油脂
■製)50■を酢酸緩衝液(0,01M、 p H6,
0) 25mに熔解した(b液)。a液にb液を4°C
に冷却しながら滴下し、1時間攪拌したa液に非イオン
脂質(ソルビタンジステアリン酸エステル)50■をエ
タノール0.5社に溶解したd液を4℃に冷却しながら
滴下し、攪拌して、滴下後、5°Cで24時間放置した
。放置後、白色沈澱が生成した溶液を遠心分離させ、上
澄液を取り除き、残った固体を酢M緩衝液で2回、蒸留
水で1回洗浄した。その後、この固体を凍結乾燥させ、
24.8■の粉末を得た。
Fruit, male side 1 Candid Cyli
After dissolving 501 g of lipase derived from S. n-dracea in 25 m of acetate buffer (0.01 M, pH 6.0), it was centrifuged to remove insoluble matter (solution a). 50μ of a nonionic surfactant (Nonion LT-221: trade name, manufactured by NOF Corporation) was added to an acetate buffer (0.01M, pH 6,
0) Melted to 25m (liquid b). Add solution B to solution A at 4°C.
Add dropwise while cooling to 4°C and stir for 1 hour.To solution A, add dropwise solution D, which is a solution of 50 μm of nonionic lipid (sorbitan distearate) dissolved in 0.5% ethanol, while cooling to 4°C, and stir. After dropping, it was left at 5°C for 24 hours. After standing, the solution in which a white precipitate was formed was centrifuged, the supernatant was removed, and the remaining solid was washed twice with vinegar M buffer and once with distilled water. This solid is then freeze-dried,
24.8 μg of powder was obtained.

更に白色沈澱を取り除いた後の上澄液にb液を4°Cに
冷却しながら滴下し、1時間攪拌した液に非イオン脂質
(ソルビタンジステアリン酸エステル)25■をエタノ
ール0.5dに溶解したa液を4°Cに冷却しながら滴
下し、攪拌して、滴下後、5°Cで24時間放置した。
Furthermore, after removing the white precipitate, liquid B was added dropwise to the supernatant liquid while cooling it to 4°C, and after stirring for 1 hour, 25 μm of nonionic lipid (sorbitan distearate) was dissolved in 0.5 d of ethanol. Solution a was added dropwise while cooling to 4°C, stirred, and left at 5°C for 24 hours after the dropwise addition.

以下前述の方法に従い17.91gの白色粉末を得た。Following the method described above, 17.91 g of white powder was obtained.

この回収操作を計4回行った。This collection operation was performed a total of four times.

第1表にその結果を示す。Table 1 shows the results.

得られた酵素と界面活性剤と脂質の複合体は、UVスペ
クトルと元素分析によって酵素を同定した。この複合体
は、水に不溶でベンゼン、クロロホルムの有機溶媒に可
溶であった。
The enzyme of the obtained complex of enzyme, surfactant, and lipid was identified by UV spectrum and elemental analysis. This complex was insoluble in water and soluble in organic solvents such as benzene and chloroform.

次に、この酵素と界面活性剤と脂質の複合体1.61g
をトリブチリン1〆に溶解させ、さらに、オクタツール
1.52Mを溶解し、水分含量が1容量%になるように
水を添加した。その後、22°Cにて30分間攪拌した
。 生成した酢酸オクチルをガスクロマトグラフ分析に
より測定した。
Next, 1.61 g of this enzyme, surfactant, and lipid complex
was dissolved in 1.52 M of tributyrin, and 1.52 M of octatool was further dissolved, and water was added so that the water content was 1% by volume. Thereafter, the mixture was stirred at 22°C for 30 minutes. The produced octyl acetate was measured by gas chromatographic analysis.

この値から次の式で合成率を求めた。From this value, the synthesis rate was calculated using the following formula.

第1表に、複合体の収量、複合体中の酵素含有量及び合
成率を示す。
Table 1 shows the yield of the complex, the enzyme content in the complex and the synthesis rate.

実施例2 実施例】で用いた界面活性剤に代えて、第2表に示す界
面活性剤50■を酢酸緩衝液(0,01M、 pH6,
0) 25mに溶解し、b液とした。
Example 2 Instead of the surfactant used in Example, 50μ of the surfactant shown in Table 2 was added to an acetate buffer (0.01M, pH 6,
0) It was dissolved in 25m and used as liquid b.

以下、実施例1と同様の操作により白色の粉末を得た。Thereafter, a white powder was obtained by the same operation as in Example 1.

その結果を第2表に示す。The results are shown in Table 2.

第1表 第2表 〔発明の効果〕 本発明の方法によれば非水系高活性酵素を製造した廃液
からさらに非水系高活性酵素を高収率で製造することが
できる。
Table 1 Table 2 [Effects of the Invention] According to the method of the present invention, a non-aqueous highly active enzyme can be further produced in high yield from the waste liquid from which the non-aqueous highly active enzyme was produced.

Claims (2)

【特許請求の範囲】[Claims] (1)0.7mg/ml以上の酵素、界面活性剤及び脂
質が溶解してなる緩衝液に更に界面活性剤を溶解し、脂
質を分散し、冷却することを特徴とする、酵素、界面活
性剤および脂質の複合体である非水系高活性酵素を製造
する方法。
(1) Enzymes and surfactants characterized by dissolving a surfactant in a buffer solution containing 0.7 mg/ml or more of an enzyme, a surfactant, and a lipid, dispersing the lipid, and cooling the solution. A method for producing a nonaqueous highly active enzyme that is a complex of an agent and a lipid.
(2)酵素の重量に対する全界面活性剤の重量の比が、
0.001〜1000(界面活性剤重量/酵素重量)で
あり、酵素の重量に対する全脂質の重量の比が、0.2
〜100(脂質重量/酵素重量)である請求項1記載の
非水系高活性酵素を製造する方法。
(2) The ratio of the weight of total surfactant to the weight of enzyme is
0.001 to 1000 (surfactant weight/enzyme weight), and the ratio of total lipid weight to enzyme weight is 0.2
2. The method for producing a non-aqueous highly active enzyme according to claim 1, wherein the ratio is 100 to 100 (lipid weight/enzyme weight).
JP2251853A 1990-09-25 1990-09-25 Production of non-aqueous highly active enzyme Pending JPH04131082A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2251853A JPH04131082A (en) 1990-09-25 1990-09-25 Production of non-aqueous highly active enzyme

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2251853A JPH04131082A (en) 1990-09-25 1990-09-25 Production of non-aqueous highly active enzyme

Publications (1)

Publication Number Publication Date
JPH04131082A true JPH04131082A (en) 1992-05-01

Family

ID=17228897

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2251853A Pending JPH04131082A (en) 1990-09-25 1990-09-25 Production of non-aqueous highly active enzyme

Country Status (1)

Country Link
JP (1) JPH04131082A (en)

Similar Documents

Publication Publication Date Title
JP4593697B2 (en) Stabilized additive in water-soluble pharmaceutical preparation of lipase and protease-containing digestive enzyme mixture, preparation containing the additive and kit for producing digestive enzyme mixture
SK9292003A3 (en) Novel mixtures of microbial enzymes
CN107034205B (en) Method for preparing high-esterification-activity lipase by using surfactant
De La Casa et al. Modification of the activities of two different lipases from Candida rugosa with dextrans
JPH1081655A (en) Production of sphingolipid and sphingolipid derivative
Assmann et al. Positional specificity of triglyceride lipases in post-heparin plasma
Matsumoto Studies on phospholipids II. Phospholipase activity of Clostridium perfringens toxin
US5082769A (en) Aqueous solution of triglyceride substrate for determination of lipase
JPH03280880A (en) Non-aqueous highly active enzyme
JPH04131082A (en) Production of non-aqueous highly active enzyme
Nagao et al. Lipase-catalyzed synthesis of fatty acid esters useful in the food industry
Boucrot et al. Resistance to the effect of phospholipase A2 of the biliary phospholipids during incubation of bile
Niino et al. Characterization of human salivary esterase in enzymatic hydrolysis of phthalate esters
JPH0279990A (en) Production of phosphatidylserine
Sugatani et al. In vitro actions of some antibiotics on phospholipases
Radominska-Pyrek et al. Synthesis and content of ether-linked glycerophospholipids in the harderian gland of rabbits
US6924130B1 (en) Enzymatic transesterification or hydrolysis of phospholipids in aqueous media
Hilton et al. Action of a microbial lipase/acyltransferase on phospholipid monolayers
JP3218794B2 (en) New surfactant-coated enzyme and its manufacturing method.
JPS6342691A (en) Modification of phospholipid
Patelski et al. Cholesterol Ester: Lysolecithin Transacylation in the Aorta1
JP2886627B2 (en) Method for producing phospholipid
Triantafyllou et al. Lipolytic and esterolytic activities in posterior lingual glands of rat: a histochemical study
JP3301489B2 (en) How to use chemically modified esterase
Nieder PARTIAL PURIFICATION AND CHARACTERIZATION OF A PHOSPHOLIPASE A1 FROM THE HEMOLYMPH OF THE TOBACCO HORNWORM, MANDUCA SEXTA